News | 2021.09.30
The DIM ELICIT (Empowering LIfe sCiences with Innovative Technologies) is organizing its closing event on Wednesday, October 20, 2021 at the Pierre-Gilles-de-Gennes Institute for Microfluidics (IPGG). The program will highlight the most emblematic projects of the DIM ELICIT with interventions in the form of pairs (biologist/technologist). This will be also an opportunity to exchange with the...
Événement | 2022.12.02
The symposium called "Epidemic, pandemic... Infodemic: the other health emergency", organized by Université Paris Cité and the Institut Pasteur, will be held on December 2, 2022. This event will take place at the Institut Pasteur (Paris, 15th arrondissement), in French. Registration is free but mandatory.(This event will be held in French)Les questions de communication et d’information...
Document de presse | 2022.10.20
Although the mechanisms by which SARS-CoV-2 enters host cells are increasingly well documented, the direct molecular interactions between virus and host remain poorly understood. Scientists from the Institut Pasteur, the French National Center for Scientific Research (CNRS), Université Paris Cité, the Institute of Network Biology (INET) Helmholtz Munich, the Donnelly Center for Cellular and...
News | 2022.03.22
In view of the ongoing war in Ukraine, the Institut Pasteur is providing funding to host Ukrainian scientists in its research laboratories.
Document de presse | 2021.11.26
From May 23 to August 13, 2021, the Institut Pasteur, in partnership with the French National Health Insurance Fund (CNAM), Santé publique France and the Ipsos institute, conducted the fourth part of the ComCor epidemiological study on circumstances and places of infection with the SARS-CoV-2 virus in France. The aim of the study was to identify the socio-demographic factors, places visited and...
News | 2020.11.24
«Pasteur Network Talent Awards» 2020 were presented on Thursday 19 November 2020 to Dr Sophie Valkenburg and Dr Roman Thibeaux by Pr Pierre-Marie Girard, Institut Pasteur vice-president international Affairs and by Prof. Stewart Cole, President of The Institut Pasteur.Due to the COVID-19 pandemic, these awards were presented by videoconference during the 52nd Council of Directors of the...
Document de presse | 2022.03.29
The SARS-CoV-2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. Although Omicron is responsible for less severe forms in the general population, immunocompromised people are still at higher risk of developing severe forms of COVID-19. Several monoclonal antibodies are currently available in clinical practice as a preventive treatment for these patients....
Document de presse | 2022.12.19
By June 2022, the Wallis and Futuna Islands, a French overseas territory, had successfully implemented a Zero-COVID strategy that significantly reduced the number of SARS-CoV-2 infections. From mid-June 2022, a gradual reopening of the borders was planned. However, the relatively low immunity in the population (due to limited vaccination coverage and the number of previous infections) and the...
News | 2023.02.22
A delegation from the Institut Pasteur will visit San Francisco during the week of February 28 to March 2, 2023, to present a series of events and workshops that will provide an overview of the Institut Pasteur-UCSF QBI partnership (Institut Pasteur-University of California, San Francisco, Quantitative Biosciences Institute). These events will also promote the establishment of a Center of...
News | 2024.07.04
Scientists have pinpointed the precise binding sites for the virus HKU1 in respiratory cells, providing a detailed picture of the infection mechanism used by the virus. Their findings shed light on other animal species that may host the virus and pave the way for the development of infection-blocking antibodies.